AG
RDHL

Aperio Group’s Redhill Biopharma RDHL Stock Holding History

Aperio Group’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$149K Buy
+18
New +$162K ﹤0.01% 2354

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aperio Group's RDHL Position: Q4 2020 in Review

Aperio Group opened a new position in Redhill Biopharma (RDHL) in Q4 2020: 18 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #2354 among its holdings.

52 funds tracked by Wall St. Rank hold RDHL as of Q4 2020.

  • Aperio Group held 18 shares of Redhill Biopharma worth $149K as of Q4 2020.
  • Redhill Biopharma was a new Aperio Group position in Q4 2020.
  • Redhill Biopharma made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2354 holding.
  • 52 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.